+ Follow NOVARTIS HEALTHCARE PHILS Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1198381
[Title] => Novartis ties up with NKTI on clinical research center
[Summary] => Novartis Healthcare Phils. and the National Kidney and Transplant Institute (NKTI) have signed a memorandum of agreement (MOA) to establish a Center of Excellence for Clinical Research that will focus on discovering and developing innovative medicine and vaccines.
[DatePublished] => 2013-09-12 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[1] => Array
(
[ArticleID] => 741282
[Title] => Novartis, WHD partners announce 'Picture of Health' contest winners
[Summary] => Novartis Healthcare Phils. and its World Hypertension Day (WHD) partners have formally announced the winners of the “Picture of Health: Healthy Blood Pressure and Blood Sugar” photo contest.
[DatePublished] => 2011-10-27 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[2] => Array
(
[ArticleID] => 601471
[Title] => World Hypertension Day tilt winners named
[Summary] => May 17 marked this year’s global commemoration of World Hypertension Day.
[DatePublished] => 2010-08-12 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[3] => Array
(
[ArticleID] => 582511
[Title] => World Health Day Celebration: Novartis turns over Low Salt Recipe Book
[Summary] => Novartis Healthcare Phils. and the Philippine Society of Hypertension (PSH), in cooperation with the Philippine Heart Association (PHA) and Philippine Society of Nephrology (PSN), formally turned over a copy of the Low Salt Recipe Book to the Department of Health (DOH) as part of the country’s commemoration of World Hypertension Day (WHD) last May 17.
[DatePublished] => 2010-06-10 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[4] => Array
(
[ArticleID] => 580426
[Title] => Novartis to continue helping poor patients
[Summary] => Novartis Healthcare Phils. has reaffirmed its commitment to implement innovative programs designed to help underprivileged Filipino patients gain access to effective cancer treatments.
[DatePublished] => 2010-06-03 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[5] => Array
(
[ArticleID] => 426327
[Title] => Program helps patients versus iron overload
[Summary] => The Philippine Society of Hematology and Blood Transfusion (PSHBT) and research-based healthcare company Novartis Healthcare Phils. Inc. are implementing an innovative program that helps Filipino patients with blood disorders gain access to information, screening and drug treatment against iron overload — an inevitable and life-threatening consequence of the repeated blood transfusions they need.
[DatePublished] => 2008-12-25 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[6] => Array
(
[ArticleID] => 277248
[Title] => Drug for kidney transplants hits RP market
[Summary] => Novartis Healthcare Phils. Inc. has announced that its newest product especially designed to prevent organ rejection for kidney transplant patients hit the Philippine market last April.
The product was launched at the recently concluded Philippine Society of Nephrology dinner-symposium held at the EDSA Shangri-La Hotel.
[DatePublished] => 2005-05-12 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[7] => Array
(
[ArticleID] => 236012
[Title] => Landmark trial shows benefits of ‘valsartan’
[Summary] => Internationally respected medical authorities reported at the American Heart Association meeting held recently in Orlando, Florida that valsartan, a drug for high blood pressure belonging to the angiotensin II receptor blocker (ARB) family, is as effective as the ACE-inhibitor captopril in reducing the risk of death and other non-fatal cardiovascular events (CV) among high-risk patients, as results of the VALIANT study show.
[DatePublished] => 2004-01-22 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[8] => Array
(
[ArticleID] => 210349
[Title] => No. 5 and eyeing no. 4
[Summary] => Three years since it was formed by the merger of Ciba Geigy and Sandoz. Novartis Healthcare Phils. now generates the fifth largest revenues in the local pharmaceutical and health case industry.
"We are behind United Laboratories, Glaxo-Smithkline, Pfizer, and Astra Zeneca," said Novartis country manager Leo Marchosky.
"We climbed up to the number five slot last year from number six, beating Roche."
[DatePublished] => 2003-06-16 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1125263
[AuthorName] => Angelica A. Angel
[SectionName] => Business As Usual
[SectionUrl] => business-as-usual
[URL] =>
)
[9] => Array
(
[ArticleID] => 151868
[Title] => 7.5-M people will go blind by 2020 due to age-related disease
[Summary] => By 2020, as many as 7.5 million people over 65 years old may suffer from vision loss due to age-related macular degeneration (AMD).
This grim scenario comes from Drs. Gisele Soubrane of the Clinique Opthamologique Universitaire de Creteil in France, and Neil M. Bressler of the Wilmer Ophthalmological Institute of the Johns Hopkins University School of Medicine in the United States, in their report published in the British Journal of Ophthalmology.
[DatePublished] => 2002-02-25 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
NOVARTIS HEALTHCARE PHILS
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1198381
[Title] => Novartis ties up with NKTI on clinical research center
[Summary] => Novartis Healthcare Phils. and the National Kidney and Transplant Institute (NKTI) have signed a memorandum of agreement (MOA) to establish a Center of Excellence for Clinical Research that will focus on discovering and developing innovative medicine and vaccines.
[DatePublished] => 2013-09-12 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[1] => Array
(
[ArticleID] => 741282
[Title] => Novartis, WHD partners announce 'Picture of Health' contest winners
[Summary] => Novartis Healthcare Phils. and its World Hypertension Day (WHD) partners have formally announced the winners of the “Picture of Health: Healthy Blood Pressure and Blood Sugar” photo contest.
[DatePublished] => 2011-10-27 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[2] => Array
(
[ArticleID] => 601471
[Title] => World Hypertension Day tilt winners named
[Summary] => May 17 marked this year’s global commemoration of World Hypertension Day.
[DatePublished] => 2010-08-12 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[3] => Array
(
[ArticleID] => 582511
[Title] => World Health Day Celebration: Novartis turns over Low Salt Recipe Book
[Summary] => Novartis Healthcare Phils. and the Philippine Society of Hypertension (PSH), in cooperation with the Philippine Heart Association (PHA) and Philippine Society of Nephrology (PSN), formally turned over a copy of the Low Salt Recipe Book to the Department of Health (DOH) as part of the country’s commemoration of World Hypertension Day (WHD) last May 17.
[DatePublished] => 2010-06-10 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[4] => Array
(
[ArticleID] => 580426
[Title] => Novartis to continue helping poor patients
[Summary] => Novartis Healthcare Phils. has reaffirmed its commitment to implement innovative programs designed to help underprivileged Filipino patients gain access to effective cancer treatments.
[DatePublished] => 2010-06-03 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[5] => Array
(
[ArticleID] => 426327
[Title] => Program helps patients versus iron overload
[Summary] => The Philippine Society of Hematology and Blood Transfusion (PSHBT) and research-based healthcare company Novartis Healthcare Phils. Inc. are implementing an innovative program that helps Filipino patients with blood disorders gain access to information, screening and drug treatment against iron overload — an inevitable and life-threatening consequence of the repeated blood transfusions they need.
[DatePublished] => 2008-12-25 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[6] => Array
(
[ArticleID] => 277248
[Title] => Drug for kidney transplants hits RP market
[Summary] => Novartis Healthcare Phils. Inc. has announced that its newest product especially designed to prevent organ rejection for kidney transplant patients hit the Philippine market last April.
The product was launched at the recently concluded Philippine Society of Nephrology dinner-symposium held at the EDSA Shangri-La Hotel.
[DatePublished] => 2005-05-12 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[7] => Array
(
[ArticleID] => 236012
[Title] => Landmark trial shows benefits of ‘valsartan’
[Summary] => Internationally respected medical authorities reported at the American Heart Association meeting held recently in Orlando, Florida that valsartan, a drug for high blood pressure belonging to the angiotensin II receptor blocker (ARB) family, is as effective as the ACE-inhibitor captopril in reducing the risk of death and other non-fatal cardiovascular events (CV) among high-risk patients, as results of the VALIANT study show.
[DatePublished] => 2004-01-22 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[8] => Array
(
[ArticleID] => 210349
[Title] => No. 5 and eyeing no. 4
[Summary] => Three years since it was formed by the merger of Ciba Geigy and Sandoz. Novartis Healthcare Phils. now generates the fifth largest revenues in the local pharmaceutical and health case industry.
"We are behind United Laboratories, Glaxo-Smithkline, Pfizer, and Astra Zeneca," said Novartis country manager Leo Marchosky.
"We climbed up to the number five slot last year from number six, beating Roche."
[DatePublished] => 2003-06-16 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1125263
[AuthorName] => Angelica A. Angel
[SectionName] => Business As Usual
[SectionUrl] => business-as-usual
[URL] =>
)
[9] => Array
(
[ArticleID] => 151868
[Title] => 7.5-M people will go blind by 2020 due to age-related disease
[Summary] => By 2020, as many as 7.5 million people over 65 years old may suffer from vision loss due to age-related macular degeneration (AMD).
This grim scenario comes from Drs. Gisele Soubrane of the Clinique Opthamologique Universitaire de Creteil in France, and Neil M. Bressler of the Wilmer Ophthalmological Institute of the Johns Hopkins University School of Medicine in the United States, in their report published in the British Journal of Ophthalmology.
[DatePublished] => 2002-02-25 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
September 12, 2013 - 12:00am
October 27, 2011 - 12:00am
August 12, 2010 - 12:00am
December 25, 2008 - 12:00am
January 22, 2004 - 12:00am
February 25, 2002 - 12:00am
